McGuff Compounding Pharmacy Services, Inc. recalls Dimercaptopropanesulfonate Sodium (DMPS), Aqueous injection solution, 50mg/mL 5 mL SDV, Rx only, McGuff Compounding Pha…
- Recall date
- February 14, 2019
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0821-2020
- FDA classification
- Class II
- Brand / firm
- McGuff Compounding Pharmacy Services, Inc.
- Sold / distributed
- Prescriptions filled for patients in the following states: AK, AZ, CA, CO, DC, FL, IN, MA, MT, NC, NJ, NY, OR, SC, TX, UT, VA, WA, and WI.
Why it was recalled
Presence of Particulate Matter: Particulates observed in vials release for dispensing.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Dimercaptopropanesulfonate Sodium (DMPS), Aqueous injection solution, 50mg/mL 5 mL SDV, Rx only, McGuff Compounding Pharmacy Services, Inc. Santa Ana, CA 92704
Get recall alerts
Free email alert whenever McGuff Compounding Pharmacy Services, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: McGuff Compounding Pharmacy Services, Inc.